Oezlem Anak

Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib

Andrew X. Zhu, Masatoshi Kudo, Eric Assénat et al. · JAMA · 2014 · 564 citations · Full text

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Nathan Fowler, Michael Dickinson, Martin Dreyling et al. · Nature Medicine · 2021 · 492 citations · Full text

Lymphoid Neoplasia, Hematology, Immunology +6

Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Carlos H. Barrios, Tae Min Kim et al. · Journal of Clinical Oncology · 2014 · 426 citations · Full text

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study

David Neal Franz, Steven Sparagana, E. Martina Bebin et al. · The Lancet Oncology · 2014 · 176 citations

Tuberous Sclerosis Complex, Neuro-oncology, Glioma +9

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors

B. Markman, Josep Tabernero, Ian E. Krop et al. · Annals of Oncology · 2012 · 145 citations

Medicine, Pharmacology, Advanced Solid Tumors +6